EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Perinatal and neonatal outcomes in gestational diabetes: The importance of the number of abnormal values in an oral glucose tolerance test

Sanna Eteläinen, Elina Keikkala, Shilpa Lingaiah iD, Matti Viljakainen, Tuija Männistö, Anneli Pouta, Risto Kaaja, Johan G Eriksson, Hannele Laivuori iD, Mika Gissler, Eero Kajantie, Marja Vääräsmäki

Acta Obstetricia et Gynecologica Scandinavica · 2025-01 · 104 (1) · 130-138

DOI: 10.1111/aogs.14999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, online erschienen am 30.10.2024. Verfasst von Sanna Eteläinen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit of Clinical Medicine, Medical Research Centre Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland. Hauptthemen laut MEDLINE: Diabetes, Gestational, Glucose Tolerance Test, Pregnancy Outcome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Gestational diabetes mellitus (GDM) is defined by one or more abnormal values in an oral glucose tolerance test (OGTT). The significance/importance of the number of abnormal values in relation to adverse perinatal and neonatal outcomes is unclear. We assessed the association of these outcomes with the number of abnormal glucose values in a 2‐h 75 g OGTT in a large register‐based cohort. Material and Methods This sub‐study of the Finnish Gestational Diabetes Study was based on the Finnish Medical Birth Register 2009 supplemented with OGTT laboratory data of 4869 pregnant women from six Finnish hospitals. The diagnostic cut‐offs in OGTT according to the Finnish guidelines for plasma samples were ≥5.3 mmol/L (fasting), ≥10.0 mmol/L 1 h or ≥8.6 mmol/L 2 h after the glucose load. As per the guidelines, women with one or several abnormal OGTT values received diet and lifestyle counseling in the primary care, self‐monitored their glucose values and received pharmacological therapy as needed. Women with GDM were categorized according to the number of abnormal glucose values. The primary outcomes, composites of adverse perinatal (pre‐eclampsia, preterm delivery, macrosomia or primary cesarean section) and neonatal outcomes (birth trauma, neonatal hypoglycemia, hyperbilirubinemia or stillbirth/perinatal mortality), were analyzed by logistic regression adjusted for maternal age, pre‐pregnancy body mass index, parity, socio‐economic status and smoking.

Results

Of all the women, 877 (18.0%) had one, 278 (5.7%) two and 79 (1.6%) three abnormal OGTT values, while 3635 (74.7%) women were normoglycemic. Women with at least two abnormal OGTT values had higher proportions of adverse perinatal composite (35.0% vs. 27.5%, adjusted odds ratio 1.36; 95% confidence interval 1.03–1.81) and neonatal composite outcomes (31.1% vs. 18.9%, adjusted odds ratio 1.88; 95% confidence interval 1.40–2.52) compared to women with one abnormal value. The risks of delivery induction and neonatal hypoglycemia were increased regardless of the number of abnormal values when compared with normoglycemic women.

Conclusions

The risk of adverse perinatal and neonatal outcomes is significantly higher in women with two or more abnormal OGTT values than in those with one abnormal value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalGlucose Tolerance TestPregnancy OutcomeHumansFemalePregnancyInfant, NewbornAdultFinlandRegistriesBlood GlucosePremature BirthFetal Macrosomia

Stichwörter der Autor:innen

composite outcomesgestational diabetesneonatal outcomesoral glucose tolerance testperinatal outcomes

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Research Unit of Clinical Medicine, Medical Research Centre Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.
  • Northern Finland Laboratory Centre (NordLab), Department of Clinical Chemistry, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Department of Government Services, Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Department of Internal Medicine, Institute of Clinical Medicine, Turku University Hospital and University of Turku, Turku, Finland.
  • Department of General Practice and Primary Health Care, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

ORCID-Profile: Shilpa Lingaiah, Hannele Laivuori

Zitieren

APA

Eteläinen, S., Keikkala, E., Lingaiah, S., Viljakainen, M., Männistö, T., Pouta, A., Kaaja, R., Eriksson, J. G., Laivuori, H., Gissler, M., Kajantie, E., & Vääräsmäki, M. (2025). Perinatal and neonatal outcomes in gestational diabetes: The importance of the number of abnormal values in an oral glucose tolerance test. Acta Obstetricia et Gynecologica Scandinavica, 104(1), 130-138. https://doi.org/10.1111/aogs.14999

Vancouver

Eteläinen S, Keikkala E, Lingaiah S, Viljakainen M, Männistö T, Pouta A, et al. Perinatal and neonatal outcomes in gestational diabetes: The importance of the number of abnormal values in an oral glucose tolerance test. Acta Obstetricia et Gynecologica Scandinavica. 2025;104(1):130-138. doi:10.1111/aogs.14999

BibTeX
@article{Etelinen2025,
  author = {Eteläinen, Sanna and Keikkala, Elina and Lingaiah, Shilpa and Viljakainen, Matti and Männistö, Tuija and Pouta, Anneli and Kaaja, Risto and Eriksson, Johan G and Laivuori, Hannele and Gissler, Mika and Kajantie, Eero and Vääräsmäki, Marja},
  title = {Perinatal and neonatal outcomes in gestational diabetes: The importance of the number of abnormal values in an oral glucose tolerance test},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  volume = {104},
  number = {1},
  pages = {130--138},
  doi = {10.1111/aogs.14999}
}
Kostenlos starten →